JP2022512395A5 - - Google Patents
Info
- Publication number
- JP2022512395A5 JP2022512395A5 JP2021533524A JP2021533524A JP2022512395A5 JP 2022512395 A5 JP2022512395 A5 JP 2022512395A5 JP 2021533524 A JP2021533524 A JP 2021533524A JP 2021533524 A JP2021533524 A JP 2021533524A JP 2022512395 A5 JP2022512395 A5 JP 2022512395A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- orf1
- acid sequence
- orf2
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024083619A JP2024100936A (ja) | 2018-12-12 | 2024-05-22 | 分泌治療モダリティを送達するためのアネロソーム |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778869P | 2018-12-12 | 2018-12-12 | |
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US62/778,869 | 2018-12-12 | ||
| US62/778,866 | 2018-12-12 | ||
| PCT/US2019/065919 WO2020123773A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes for delivering secreted therapeutic modalities |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024083619A Division JP2024100936A (ja) | 2018-12-12 | 2024-05-22 | 分泌治療モダリティを送達するためのアネロソーム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512395A JP2022512395A (ja) | 2022-02-03 |
| JP2022512395A5 true JP2022512395A5 (https=) | 2022-12-20 |
Family
ID=69160343
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533524A Pending JP2022512395A (ja) | 2018-12-12 | 2019-12-12 | 分泌治療モダリティを送達するためのアネロソーム |
| JP2024083619A Pending JP2024100936A (ja) | 2018-12-12 | 2024-05-22 | 分泌治療モダリティを送達するためのアネロソーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024083619A Pending JP2024100936A (ja) | 2018-12-12 | 2024-05-22 | 分泌治療モダリティを送達するためのアネロソーム |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230048858A1 (https=) |
| EP (1) | EP3894568A2 (https=) |
| JP (2) | JP2022512395A (https=) |
| KR (1) | KR20210131309A (https=) |
| CN (1) | CN113631717A (https=) |
| AU (1) | AU2019396520A1 (https=) |
| BR (1) | BR112021009379A2 (https=) |
| CA (1) | CA3119531A1 (https=) |
| IL (1) | IL283778A (https=) |
| MX (1) | MX2021006943A (https=) |
| WO (1) | WO2020123773A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018201160A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| CA3073449A1 (en) | 2017-09-25 | 2019-03-28 | Agrospheres, Inc. | Compositions and methods for scalable production and delivery of biologicals |
| MX2021006977A (es) * | 2018-12-12 | 2021-10-13 | Flagship Pioneering Innovations V Inc | Anellosomas y metodos de uso. |
| CA3119814A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering protein replacement therapeutic modalities |
| MX2022016475A (es) * | 2020-06-17 | 2023-04-11 | Flagship Pioneering Innovations V Inc | Metodos de identificacion y caracterizacion de anellovirus y usos de los mismos. |
| WO2022094238A2 (en) * | 2020-10-29 | 2022-05-05 | Flagship Pioneering Innovations V, Inc. | Chicken anemia virus (cav)-based vectors |
| EP4288115A4 (en) * | 2021-02-08 | 2025-06-18 | Flagship Pioneering Innovations V, Inc. | Hybrid aav-anellovectors |
| EP4337235A4 (en) * | 2021-05-12 | 2025-07-02 | Flagship Pioneering Innovations V Inc | ANELLOVECTORS AND METHODS OF USE |
| IL311987A (en) * | 2021-10-12 | 2024-06-01 | Flagship Pioneering Innovations V Inc | New analvector compositions and methods |
| CN118284411A (zh) * | 2021-10-12 | 2024-07-02 | 旗舰先锋创新V股份有限公司 | 新颖的指环载体组合物和方法 |
| TW202430215A (zh) | 2022-12-14 | 2024-08-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 用於將治療劑遞送至骨之組成物和方法 |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
| CN117695410B (zh) * | 2024-02-06 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | CRISPR/Cas9纳米抗菌剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| JP7103750B2 (ja) * | 2013-12-12 | 2022-07-20 | ザ・ブロード・インスティテュート・インコーポレイテッド | ゲノム編集のためのＣＲＩＳＰＲ－Ｃａｓ系及び組成物の送達、使用及び治療適用 |
| CN108291216B (zh) * | 2015-09-24 | 2022-09-16 | 宾夕法尼亚州大学信托人 | 用于治疗补体介导的疾病的组合物和方法 |
| IL271275B1 (en) * | 2017-06-13 | 2026-04-01 | Flagship Pioneering Innovations V Inc | Preparations containing croons and their uses |
| MX2020003888A (es) * | 2017-10-18 | 2020-11-06 | Regenxbio Inc | Anticuerpos terapeuticos postraduccionalmente modificados completamente humanos. |
-
2019
- 2019-12-12 AU AU2019396520A patent/AU2019396520A1/en active Pending
- 2019-12-12 KR KR1020217021775A patent/KR20210131309A/ko active Pending
- 2019-12-12 US US17/413,207 patent/US20230048858A1/en not_active Abandoned
- 2019-12-12 BR BR112021009379-6A patent/BR112021009379A2/pt unknown
- 2019-12-12 EP EP19836323.6A patent/EP3894568A2/en active Pending
- 2019-12-12 CN CN201980091251.6A patent/CN113631717A/zh active Pending
- 2019-12-12 WO PCT/US2019/065919 patent/WO2020123773A2/en not_active Ceased
- 2019-12-12 JP JP2021533524A patent/JP2022512395A/ja active Pending
- 2019-12-12 CA CA3119531A patent/CA3119531A1/en active Pending
- 2019-12-12 MX MX2021006943A patent/MX2021006943A/es unknown
-
2021
- 2021-06-07 IL IL283778A patent/IL283778A/en unknown
-
2024
- 2024-05-22 JP JP2024083619A patent/JP2024100936A/ja active Pending
-
2025
- 2025-06-17 US US19/240,368 patent/US20260009050A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512395A5 (https=) | ||
| JP2022513459A5 (https=) | ||
| JP2022513797A5 (https=) | ||
| JP2022514501A5 (https=) | ||
| US20260009050A1 (en) | Anellosomes for delivering secreted therapeutic modalities | |
| KR100645851B1 (ko) | 단백질 중공 나노 입자와 그것을 이용한 물질운반체, 및세포로의 물질도입방법 | |
| JP2020524993A5 (https=) | ||
| CN102121023B (zh) | 突变型人纤溶酶原kringle5及其制备方法及应用 | |
| WO1986007609A1 (fr) | VECTEUR D'EXPRESSION DE L'INTERFERON-gamma DANS LES CELLULES DE MAMMIFERE, PROCEDE POUR SA MISE EN OEUVRE, PRODUIT OBTENU ET COMPOSITION PHARMACEUTIQUE CONTENANT L'INTERFERON-gamma | |
| JP4280786B2 (ja) | 同一のｎ末端を有する塩基性繊維芽細胞増殖因子の高レベル発現 | |
| WO2025102504A1 (zh) | 基于i型内含子的环状rna制备方法及其应用 | |
| CN106167791B (zh) | MSC-TNF α-AB干细胞及其制备方法和应用 | |
| TW202223095A (zh) | 串聯指環病毒構築體 | |
| CN114213505B (zh) | 一种适用于特异感染u87-mg细胞的腺相关病毒突变体 | |
| JP2018148865A (ja) | ボルナウイルスベクター及びその利用 | |
| CN101016548A (zh) | 可溶性转化生长因子βⅡ型受体/γ－干扰素重组融合蛋白及其制备 | |
| CN110079553B (zh) | 一种增强猪抗病毒性疫病的生物制剂 | |
| CN115975053B (zh) | 靶向新型冠状病毒的疫苗 | |
| CN113072646A (zh) | 靶向egfr的肿瘤核酸疫苗 | |
| KR20260007637A (ko) | 원형 rna 및 이의 제조방법 | |
| CN118388633A (zh) | 抑制新生血管生成的重组胶原蛋白、其制备方法及应用 | |
| CN109847054B (zh) | TgGRA15在制备诱导I型干扰素的药物中的应用 | |
| CN117904193A (zh) | 加载miRNAs的外泌体生发制剂及其应用 | |
| CN119954974B (zh) | 一种工程化巨噬细胞，其制备方法及抗纤维化的应用 | |
| CN120098148B (zh) | 一种工程化巨噬细胞制备及抗纤维化的应用 |